Skip to main
ASPI

ASPI Stock Forecast & Price Target

ASPI Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

ASP Isotopes Inc. has demonstrated substantial revenue growth, reporting approximately $16.7 million in Q4, reflecting an annual increase of about 1299.6% and a sequential rise of 241.7%, driven primarily by heightened product revenue and significant contributions from construction services. The management’s positive sentiment regarding anticipated volume growth and early SPECT dose deliveries positions the company for a transformative phase, especially with indications of a potential revenue surge beginning mid-2026. Furthermore, the broader market outlook for helium, expected to double in demand by 2035 with a projected value of approximately USD 132 million in 2025, underscores the strategic importance of ASP Isotopes’ advancements in isotope production technology.

Bears say

ASP Isotopes Inc. reported a gross margin that significantly missed estimates, declining to approximately 8.7% in 3Q25 from 27.0% in the prior year, highlighting inefficiencies and operational challenges. The company also faced a widening net loss of $75.7 million in 4Q25, compared to $9.2 million in 4Q24, indicating deteriorating financial performance amid ongoing revenue delays related to isotope production. Furthermore, the adverse impact of broader economic factors, including decreased liquidity and credit availability, increased inflation, and rising interest rates, raises concerns about the company's ability to meet its strategic goals and maintain operational stability.

ASPI has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ASP Isotopes Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ASP Isotopes Inc (ASPI) Forecast

Analysts have given ASPI a Buy based on their latest research and market trends.

According to 2 analysts, ASPI has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ASP Isotopes Inc (ASPI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.